Search results
ACER Down Despite FDA Nod for Urea Cycle Disorders Drug
Zacks via Yahoo Finance· 1 year agoThe FDA approves Acer Therapeutics' (ACER) Olpruva (sodium phenylbutyrate) to treat certain patients...
Acer Therapeutics (ACER) Gets CRL for Urea Cycle Disorders Drug
Zacks via Yahoo Finance· 2 years agoAcer Therapeutics' (ACER) new drug application for ACER-001 to treat urea cycle disorders faces...
What Are Metabolic Disorders?
Verywell Health via Yahoo News· 1 year agoMetabolic disorders are medical conditions that impact your metabolism, a wide array of processes that enable proper bodily functioning and balance....
Acer (ACER) to Report Q4 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 1 year agoWe expect investors to focus on updates of Acer Therapeutics’ ACER pipeline and revenue guidance for...
Biotech Stock Roundup: GILD's HIV Drug Approval, PRQR Surges on LLY Deal & More
Zacks via Yahoo Finance· 1 year agoThe biotech sector was in focus with many important pipeline and regulatory updates. Collaboration...
Acer (ACER) to Get Acquired by Zevra for $91M, Stock Up
Zacks via Yahoo Finance· 10 months agoAcer Therapeutics ACER announced its definitive agreement to be acquired by Zevra Therapeutics ZVRA,...
Lichenification
Verywell Health via Yahoo News· 1 year agoLesions caused by lichenification are characterized as thickened and hardened skin. This article discusses the symptoms of lichenification, its causes,...
Biotech Stock Roundup: MRNA's Jab Update, ACER Down on Regulatory News & More
Zacks via Yahoo Finance· 2 years agoThe biotech sector has been in the spotlight in the past week with important pipeline and regulatory...
ACER's Stock Down on Failure of Phase II Study, Cash Updates
Zacks via Yahoo Finance· 1 year agoACER announces the failure of its phase IIa study of ACER-801 to treat vasomotor symptoms associated...
Zevra Therapeutics Inc (ZVRA) Earnings: A Mixed Bag Against Analyst Estimates with Significant ...
GuruFocus.com via Yahoo Finance· 3 months agoRevenue: Q4 2023 net revenue reached $13.2 million, significantly surpassing analyst estimates of...